Amyotrophic Lateral Sclerosis in United Arab Emirates

About Amyotrophic Lateral Sclerosis

Neurology

Treatment access in United Arab Emirates

The UAE recognises a formal Named Patient / compassionate-use pathway via MOHAP and the Department of Health Abu Dhabi (DoH). Physicians apply on behalf of individual patients for drugs not registered in-country.

For patients in United Arab Emirates with amyotrophic lateral sclerosis whose required therapy is not locally registered, a Named Patient Program pathway typically applies.

How Reserve Meds supports patients with amyotrophic lateral sclerosis in United Arab Emirates

1. Patient or physician contacts us with disease details and therapy requested.
2. We verify eligibility in United Arab Emirates and confirm US supply.
3. Treating physician in United Arab Emirates issues prescription and justification.
4. We file United Arab Emirates-specific NPP/personal-import paperwork.
5. We source the drug from a DSCSA-compliant US specialty wholesaler.
6. Cold-chain shipment to the patient's physician or hospital pharmacy in United Arab Emirates.

Patient support throughout

• Case manager from request through delivery.
• Documentation translation where needed.
• Physician-to-physician support for clinical justification.
• Re-supply coordination for chronic therapy.

Start a request

Start a Amyotrophic Lateral Sclerosis request in United Arab Emirates